Chancellor Rachel Reeves Intends Targeted Action on Household Expenses in Forthcoming Budget
Treasury head Rachel Reeves has announced she is preparing "focused action to tackle household expense challenges" in the forthcoming Budget.
During an interview with media outlets, she emphasized that reducing price rises is a collective task of both the administration and the Bank of England.
The UK's price growth is projected to be the highest among the G7 advanced economies this calendar year and next.
Potential Utility Cost Interventions
It is understood the administration could take action to bring down energy bills, such as by slashing the present 5% level of VAT applied on energy.
Another option is to cut some of the policy costs currently included in bills.
Fiscal Constraints and Expert Predictions
The government will receive the next draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for such actions.
The consensus from most analysts is that Reeves will have to declare higher taxes or budget cuts in order to adhere to her voluntary debt limits.
Earlier on the same day, estimates suggested there was a £22 billion gap for the Treasury chief to address, which is at the more modest range of expectations.
"It is a joint job between the central bank and the administration to further reduce some of the causes of inflation," the Chancellor told the BBC in the US capital, at the conferences of the IMF and World Bank.
Revenue Commitments and Global Concerns
While a great deal of the attention has been on expected tax rises, the chancellor said the most recent data from the OBR had not changed her pledge to election pledges not to increase rates on earnings tax, VAT or social security contributions.
She attributed an "uncertain world" with increasing international and commercial issues for the fiscal revenue measures, likely to be directed on those "with the broadest shoulders."
International Economic Disputes
Referring to apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security invariably come first."
Recent declaration by China to tighten trade restrictions on critical minerals and other resources that are essential for advanced tech production led American leader Donald Trump to suggest an further 100% tariff on imports from China, raising the prospect of an full-scale commercial conflict between the two largest economies.
The US Treasury Secretary called China's move "commercial pressure" and "a international production power grab."
Questioned on accepting the American proposal to join its dispute with China, Reeves said she was "very concerned" by China's measures and urged the Beijing authorities "to avoid restrictions and restrict access."
She said the move was "bad for the global economy and generates additional headwinds."
"It is my opinion there are fields where we must address Chinese policies, but there are also significant prospects to trade with China's economy, including banking sector and other areas of the economy. We've got to maintain that balance appropriate."
The chancellor also confirmed she was cooperating with other major economies "regarding our own critical minerals strategy, so that we are reduced dependence."
Health Service Medicine Pricing and Funding
The Chancellor also acknowledged that the cost the NHS spends on pharmaceuticals could rise as a result of current negotiations with the US government and its drugs companies, in return for reduced taxes and investment.
Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with several blaming the insufficient payments they are getting.
Recently, the Science Minister said the cost the NHS pays for medicines would need to increase to stop businesses and drug research funding departing from the United Kingdom.
The Chancellor stated to media: "It has been observed as a result of the payment system, that clinical trials, new drugs have not been available in the United Kingdom in the manner that they are in other European countries."
"Our aim is to guarantee that individuals receiving care from the NHS are able to access the best life-saving drugs in the world. And so we are examining these issues, and... aiming to attract additional capital into the UK."